Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
Stingl JC, Ettrich T, Muche R, Wiedom M, Brockmöller J, Seeringer A, Seufferlein T. Stingl JC, et al. Among authors: seufferlein t. BMC Cancer. 2011 Aug 18;11:360. doi: 10.1186/1471-2407-11-360. BMC Cancer. 2011. PMID: 21851602 Free PMC article. Clinical Trial.
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2.
Märten A, Schmidt J, Ose J, Harig S, Abel U, Münter MW, Jäger D, Friess H, Mayerle J, Adler G, Seufferlein T, Gress T, Schmid R, Büchler MW. Märten A, et al. Among authors: seufferlein t. BMC Cancer. 2009 May 26;9:160. doi: 10.1186/1471-2407-9-160. BMC Cancer. 2009. PMID: 19470159 Free PMC article. Clinical Trial.
Pharmacogenetic predictors for EGFR-inhibitor-associated skin toxicity.
Parmar S, Schumann C, Rüdiger S, Boeck S, Heinemann V, Kächele V, Seeringer A, Paul T, Seufferlein T, Stingl JC. Parmar S, et al. Among authors: seufferlein t. Pharmacogenomics J. 2013 Apr;13(2):181-8. doi: 10.1038/tpj.2011.51. Epub 2011 Dec 13. Pharmacogenomics J. 2013. PMID: 22158333
Regorafenib.
Ettrich TJ, Seufferlein T. Ettrich TJ, et al. Among authors: seufferlein t. Recent Results Cancer Res. 2014;201:185-96. doi: 10.1007/978-3-642-54490-3_10. Recent Results Cancer Res. 2014. PMID: 24756792 Review.
[Therapy in pancreatic cancer - and still it moves along!].
Ettrich TJ, Perkhofer L, Seufferlein T. Ettrich TJ, et al. Among authors: seufferlein t. Dtsch Med Wochenschr. 2015 Apr;140(7):508-11. doi: 10.1055/s-0041-101154. Epub 2015 Mar 31. Dtsch Med Wochenschr. 2015. PMID: 25826035 German.
[Personalized tumor therapy for gastrointestinal tumors].
Ettrich TJ, Perkhofer L, Seufferlein T. Ettrich TJ, et al. Among authors: seufferlein t. Internist (Berl). 2015 Sep;56(9):1069-78. doi: 10.1007/s00108-015-3752-6. Internist (Berl). 2015. PMID: 26148698 Review. German.
456 results